Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

door Ko, A H, Hwang, J, Venook, A P, Abbruzzese, J L, Bergsland, E K, Tempero, M A
Gepubliceerd in 2005

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

door Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K
Gepubliceerd in 2013

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates

door Kelley, R. K., Nimeiri, H. S., Munster, P. N., Vergo, M. T., Huang, Y., Li, C.-M., Hwang, J., Mulcahy, M. F., Yeh, B. M., Kuhn, P., Luttgen, M. S., Grabowsky, J. A., Stucky-Marshall, L., Korn, W. M., Ko, A. H., Bergsland, E. K., Benson, A. B., Venook, A. P.
Gepubliceerd in 2013

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

door Abou-Alfa, G.K., Meyer, T., Cheng, A.-L., El-Khoueiry, A.B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y.H., Park, J.-W., Blanc, J.-F., Bolondi, L., Klümpen, H.-J., Chan, S.L., Zagonel, V., Pressiani, T., Ryu, M.-H., Venook, A.P., Hessel, C., Borgman-Hagey, A.E., Schwab, G., Kelley, R.K.
Gepubliceerd in N Engl J Med (2018)